Biological patent thickets and delayed access to biosimilars, an American problem.

Authors:
Goode R; Chao B.

Journal:
J Law Biosci

Publication Year: 2022

DOI:
10.1093/jlb/lsac022

PMCID:
PMC9439849

PMID:
36072417

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Law Biosci

Abbreviation: J Law Biosci

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medical Ethics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Anticipation in the biosciences and the human right to science.
Boggio A. (2024) - Transparency Score: 2/6
CRISPR-phage antibacterials to address the antibiotic resistance crisis: scientific, economic, and …
Pacia DM; Brown BL; Minssen T and 1 more (2024) - Transparency Score: 3/6
Purpose definition as a crucial step for determining the legal basis under the GDPR: implications f…
Becker R; Chokoshvili D; Thorogood A and 5 more (2024) - Transparency Score: 2/6
Cryopreservation and current legal problems: seeking and selling immortality.
Mullock A; Romanis EC. (2023) - Transparency Score: 2/6
Defusing the legal and ethical minefield of epigenetic applications in the military, defense, and s…
Dalpé G; Huerne K; Dupras C and 14 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"table 1 and figures3 and 4 27 see annex a for raw data"

Code Sharing
Evidence found in paper:

"Sufficiency of Disclosure and the great divide between the U.S. and Europe, McAndrews News & Insights IP Updates (Feb. 26, 2014) available at https://www.mcandrews-ip.com/sufficiency-disclosure-and-the/"

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025